3-Iodobenzylguanidine
The therapeutic efficacy of Iobenguane can be decreased when used in combination with Lofexidine.
Acebutolol
Lofexidine may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Acemetacin
The therapeutic efficacy of Lofexidine can be decreased when used in combination with Acemetacin.
Advertisement
Aldesleukin
The risk or severity of adverse effects can be increased when Lofexidine is combined with Aldesleukin.
Alfuzosin
Alfuzosin may increase the hypotensive activities of Lofexidine.
Aliskiren
Lofexidine may increase the hypotensive activities of Aliskiren.
Advertisement
Alprenolol
Lofexidine may increase the atrioventricular blocking (AV block) activities of Alprenolol.
Ambrisentan
Lofexidine may increase the hypotensive activities of Ambrisentan.
Amifostine
Lofexidine may increase the hypotensive activities of Amifostine.
Advertisement
Amifostine Anhydrous
Lofexidine may increase the hypotensive activities of Amifostine.
Amiloride
The risk or severity of adverse effects can be increased when Lofexidine is combined with Amiloride.
Amineptin
Amineptine may decrease the antihypertensive activities of Lofexidine.
Amiodarone
The risk or severity of adverse effects can be increased when Amiodarone is combined with Lofexidine.
Amitriptyline
Amitriptyline may decrease the antihypertensive activities of Lofexidine.
Amlodipine
Amlodipine may increase the hypotensive activities of Lofexidine.
Amobarbital
Amobarbital may increase the hypotensive activities of Lofexidine.
Amoxapine
Amoxapine may decrease the antihypertensive activities of Lofexidine.
Amphetamine
Amphetamine may increase the hypotensive activities of Lofexidine.
Amphotericin B
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Lofexidine.
amphotericin B liposomal
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Lofexidine.
Amyl Nitrite
The risk or severity of adverse effects can be increased when Lofexidine is combined with Amyl Nitrite.
Apomorphine
The risk or severity of adverse effects can be increased when Apomorphine is combined with Lofexidine.
Apraclonidine
The risk or severity of adverse effects can be increased when Lofexidine is combined with Apraclonidine.
Aripiprazole
Aripiprazole may increase the hypotensive activities of Lofexidine.
Arsenic Trioxide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Lofexidine.
Atenolol
Lofexidine may increase the atrioventricular blocking (AV block) activities of Atenolol.
Avanafil
Avanafil may increase the antihypertensive activities of Lofexidine.
Azilsartan
The risk or severity of adverse effects can be increased when Lofexidine is combined with Azilsartan medoxomil.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Lofexidine is combined with Azilsartan medoxomil.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Lofexidine is combined with Azilsartan medoxomil.
Barbexaclone
Barbexaclone may increase the hypotensive activities of Lofexidine.
Barbital
Barbital may increase the hypotensive activities of Lofexidine.
Benazepril
Benazepril may increase the hypotensive activities of Lofexidine.
Bendroflumethiazide
Bendroflumethiazide may increase the hypotensive activities of Lofexidine.
Benzylpenicilloyl polylysine
Lofexidine may decrease effectiveness of Benzylpenicilloyl Polylysine as a diagnostic agent.
Bepridil
Bepridil may increase the hypotensive activities of Lofexidine.
Betaxolol
Lofexidine may increase the atrioventricular blocking (AV block) activities of Betaxolol.
Bethanidine
Bethanidine may increase the hypotensive activities of Lofexidine.
Bimatoprost
Bimatoprost may increase the hypotensive activities of Lofexidine.
Bisoprolol
Lofexidine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Bopindolol
Lofexidine may increase the atrioventricular blocking (AV block) activities of Bopindolol.
Bortezomib
The risk or severity of adverse effects can be increased when Bortezomib is combined with Lofexidine.
Bosentan
Bosentan may increase the hypotensive activities of Lofexidine.
Bretylium
Bretylium may increase the hypotensive activities of Lofexidine.
Brimonidine
Brimonidine may increase the antihypertensive activities of Lofexidine.
Bromocriptine
Bromocriptine may increase the hypertensive and vasoconstricting activities of Lofexidine.
Bumetanide
The risk or severity of adverse effects can be increased when Lofexidine is combined with Bumetanide.
Bunazosin
Bunazosin may decrease the vasoconstricting activities of Lofexidine.
Bupivacaine
The risk or severity of adverse effects can be increased when Bupivacaine is combined with Lofexidine.
Bupranolol
Lofexidine may increase the atrioventricular blocking (AV block) activities of Bupranolol.
Cabergoline
Cabergoline may increase the hypertensive and vasoconstricting activities of Lofexidine.
Cafedrine
Lofexidine may increase the hypotensive activities of Cafedrine.
Canagliflozin
The risk or severity of adverse effects can be increased when Lofexidine is combined with Canagliflozin.
Canagliflozin Anhydrous
The risk or severity of adverse effects can be increased when Lofexidine is combined with Canagliflozin.
Candesartan
Lofexidine may increase the hypotensive activities of Candesartan.
Candesartan Cilexetil
Candesartan cilexetil may increase the hypotensive activities of Lofexidine.
Captopril
Captopril may increase the hypotensive activities of Lofexidine.
Carteolol
Lofexidine may increase the atrioventricular blocking (AV block) activities of Carteolol.
Carvedilol
Lofexidine may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Celiprolol
Lofexidine may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Chlorothiazide
Chlorothiazide may increase the hypotensive activities of Lofexidine.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Lofexidine.
Chlorthalidone
Chlorthalidone may increase the hypotensive activities of Lofexidine.
Cicletanine
Lofexidine may increase the hypotensive activities of Cicletanine.
Cilazapril
Cilazapril may increase the hypotensive activities of Lofexidine.
Clevidipine
The risk or severity of adverse effects can be increased when Lofexidine is combined with Clevidipine.
Clevidipine butyrate
The risk or severity of adverse effects can be increased when Lofexidine is combined with Clevidipine.
Clofarabine
The risk or severity of adverse effects can be increased when Clofarabine is combined with Lofexidine.
Clomipramine
Clomipramine may decrease the antihypertensive activities of Lofexidine.
Clonidine
Clonidine may increase the hypotensive activities of Lofexidine.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Lofexidine.
Conivaptan
The risk or severity of adverse effects can be increased when Conivaptan is combined with Lofexidine.
Cryptenamine
Cryptenamine may increase the hypotensive activities of Lofexidine.
Cyclobenzaprine
Cyclobenzaprine may decrease the antihypertensive activities of Lofexidine.
Cyclopenthiazide
Lofexidine may increase the hypotensive activities of Cyclopenthiazide.
Cyclothiazide
Cyclothiazide may increase the hypotensive activities of Lofexidine.
Dapagliflozin
The risk or severity of adverse effects can be increased when Lofexidine is combined with Dapagliflozin.
Debrisoquin
Debrisoquin may increase the hypotensive activities of Lofexidine.
Deserpidine
Lofexidine may increase the hypotensive activities of Deserpidine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Lofexidine.
Desipramine
Desipramine may decrease the antihypertensive activities of Lofexidine.
Desvenlafaxine
Desvenlafaxine may increase the tachycardic activities of Lofexidine.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Lofexidine is combined with Dexmedetomidine.
Diazoxide
Diazoxide may increase the hypotensive activities of Lofexidine.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Lofexidine is combined with Diclofenamide.
Dihydralazine
Dihydralazine may increase the hypotensive activities of Lofexidine.
Dihydroergotamine
Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Lofexidine.
Diltiazem
Diltiazem may increase the hypotensive activities of Lofexidine.
Dinutuximab
The risk or severity of adverse effects can be increased when Lofexidine is combined with Dinutuximab.
Dipyridamole
The risk or severity of adverse effects can be increased when Lofexidine is combined with Dipyridamole.
Dorzolamide
Dorzolamide may increase the hypotensive activities of Lofexidine.
Dothiepin
Dosulepin may decrease the antihypertensive activities of Lofexidine.
Doxazosin
Doxazosin may increase the hypotensive activities of Lofexidine.
Doxepin
Doxepin may decrease the antihypertensive activities of Lofexidine.
Duloxetine
Lofexidine may increase the orthostatic hypotensive activities of Duloxetine.
Empagliflozin
The risk or severity of adverse effects can be increased when Lofexidine is combined with Empagliflozin.
Enalapril
Enalapril may increase the hypotensive activities of Lofexidine.
Enalaprilat
Lofexidine may increase the hypotensive activities of Enalaprilat.
Enalaprilat Anhydrous
Lofexidine may increase the hypotensive activities of Enalaprilat.
Eplerenone
The risk or severity of adverse effects can be increased when Lofexidine is combined with Eplerenone.
Epoprostenol
Epoprostenol may increase the hypotensive activities of Lofexidine.
Eprosartan
Eprosartan may increase the hypotensive activities of Lofexidine.
ergoloid mesylates, USP
Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Lofexidine.
Ergonovine
Ergonovine may increase the hypertensive and vasoconstricting activities of Lofexidine.
Ergotamine
Ergotamine may increase the hypertensive and vasoconstricting activities of Lofexidine.
Esmolol
Lofexidine may increase the atrioventricular blocking (AV block) activities of Esmolol.
Ethacrynate
The risk or severity of adverse effects can be increased when Lofexidine is combined with Etacrynic acid.
Ethacrynic Acid
The risk or severity of adverse effects can be increased when Lofexidine is combined with Etacrynic acid.
Felodipine
Felodipine may increase the hypotensive activities of Lofexidine.
Fenoldopam
Fenoldopam may increase the hypotensive activities of Lofexidine.
Ferulic Acid
Lofexidine may increase the hypotensive activities of Ferulic acid.
Fosinopril
Fosinopril may increase the hypotensive activities of Lofexidine.
Furazolidone
Furazolidone may increase the hypotensive activities of Lofexidine.
Furosemide
The risk or severity of adverse effects can be increased when Lofexidine is combined with Furosemide.
Guanabenz
Guanabenz may increase the hypotensive activities of Lofexidine.
Guanadrel
Guanadrel may increase the hypotensive activities of Lofexidine.
Guanethidine
Guanethidine may increase the hypotensive activities of Lofexidine.
Guanfacine
Guanfacine may increase the hypotensive activities of Lofexidine.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Lofexidine.
Hexobarbital
Hexobarbital may increase the hypotensive activities of Lofexidine.
Hyaluronidase
Hyaluronidase may increase the vasoconstricting activities of Lofexidine.
Hyaluronidase, Ovine
Hyaluronidase may increase the vasoconstricting activities of Lofexidine.
Hydralazine
Hydralazine may increase the hypotensive activities of Lofexidine.
Hydrochlorothiazide
Hydrochlorothiazide may increase the hypotensive activities of Lofexidine.
Hydroflumethiazide
Hydroflumethiazide may increase the hypotensive activities of Lofexidine.
Iloprost
The risk or severity of adverse effects can be increased when Iloprost is combined with Lofexidine.
Imidapril
The risk or severity of adverse effects can be increased when Imidapril is combined with Lofexidine.
Imipramine
Imipramine may decrease the antihypertensive activities of Lofexidine.
Indapamide
Indapamide may increase the hypotensive activities of Lofexidine.
Indoramin
Indoramin may increase the hypotensive activities of Lofexidine.
Iproniazid
Iproniazid may increase the hypotensive activities of Lofexidine.
Irbesartan
Irbesartan may increase the hypotensive activities of Lofexidine.
Isocarboxazid
Isocarboxazid may increase the hypotensive activities of Lofexidine.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Lofexidine.
Isosorbide Dinitrate
The risk or severity of adverse effects can be increased when Lofexidine is combined with Isosorbide Dinitrate.
Isosorbide Mononitrate
The risk or severity of adverse effects can be increased when Lofexidine is combined with Isosorbide Mononitrate.
Isoxsuprine
The risk or severity of adverse effects can be increased when Lofexidine is combined with Isoxsuprine.
Isradipine
Isradipine may increase the hypotensive activities of Lofexidine.
Ketanserin
Ketanserin may increase the hypotensive activities of Lofexidine.
Labetalol
Lofexidine may increase the atrioventricular blocking (AV block) activities of Labetalol.
Lacidipine
Lofexidine may increase the hypotensive activities of Lacidipine.
Latanoprost
Latanoprost may increase the hypotensive activities of Lofexidine.
Lercanidipine
Lercanidipine may increase the hypotensive activities of Lofexidine.
Levobunolol
The risk or severity of adverse effects can be increased when Lofexidine is combined with Levobunolol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Lofexidine.
Levodopa
Lofexidine may increase the orthostatic hypotensive activities of Levodopa.
Levomilnacipran
Levomilnacipran may increase the tachycardic activities of Lofexidine.
Levosimendan
The risk or severity of adverse effects can be increased when Levosimendan is combined with Lofexidine.
Lisinopril
Lisinopril may increase the hypotensive activities of Lofexidine.
Lisinopril Anhydrous
Lisinopril may increase the hypotensive activities of Lofexidine.
Losartan
Losartan may increase the hypotensive activities of Lofexidine.
Macitentan
Lofexidine may increase the hypotensive activities of Macitentan.
Manidipine
Lofexidine may increase the hypotensive activities of Manidipine.
Mannitol
The risk or severity of adverse effects can be increased when Lofexidine is combined with Mannitol.
Mecamylamine
Mecamylamine may increase the hypotensive activities of Lofexidine.
Mephobarbital
Methylphenobarbital may increase the hypotensive activities of Lofexidine.
Mepirodipine
Lofexidine may increase the antihypertensive activities of Barnidipine.
Methazolamide
The risk or severity of adverse effects can be increased when Lofexidine is combined with Methazolamide.
Methohexital
Methohexital may increase the hypotensive activities of Lofexidine.
Methyclothiazide
The risk or severity of adverse effects can be increased when Lofexidine is combined with Methyclothiazide.
Methyldopa
Methyldopa may increase the hypotensive activities of Lofexidine.
METHYLDOPA ANHYDROUS
Methyldopa may increase the hypotensive activities of Lofexidine.
Methylene blue
Methylene blue may increase the hypotensive activities of Lofexidine.
Methylergonovine
Methylergometrine may increase the hypertensive and vasoconstricting activities of Lofexidine.
Methylnaltrexone
The risk or severity of adverse effects can be increased when Lofexidine is combined with Methylnaltrexone.
Methylphenidate
Methylphenidate may decrease the antihypertensive activities of Lofexidine.
Metipranolol
Metipranolol may increase the hypotensive activities of Lofexidine.
Metolazone
Metolazone may increase the hypotensive activities of Lofexidine.
Metoprolol
Lofexidine may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Metyrosine
Lofexidine may increase the hypotensive activities of Metyrosine.
Mianserin
The therapeutic efficacy of Lofexidine can be decreased when used in combination with Mianserin.
Mibefradil
Mibefradil may increase the hypotensive activities of Lofexidine.
Milnacipran
Milnacipran may increase the tachycardic activities of Lofexidine.
Minaprine
Minaprine may increase the hypotensive activities of Lofexidine.
Minoxidil
Minoxidil may increase the hypotensive activities of Lofexidine.
Mirtazapine
Mirtazapine may decrease the antihypertensive activities of Lofexidine.
Moclobemide
Moclobemide may increase the hypotensive activities of Lofexidine.
Moexipril
Moexipril may increase the hypotensive activities of Lofexidine.
Molsidomine
Molsidomine may increase the hypotensive activities of Lofexidine.
Morphine
The risk or severity of adverse effects can be increased when Lofexidine is combined with Morphine.
Moxonidine
Moxonidine may increase the hypotensive activities of Lofexidine.
Nabilone
The risk or severity of adverse effects can be increased when Lofexidine is combined with Nabilone.
Nadolol
Lofexidine may increase the atrioventricular blocking (AV block) activities of Nadolol.
Naloxegol
The risk or severity of adverse effects can be increased when Lofexidine is combined with Naloxegol.
Nebivolol
Lofexidine may increase the atrioventricular blocking (AV block) activities of Nebivolol.
Nesiritide
The risk or severity of adverse effects can be increased when Lofexidine is combined with Nesiritide.
Nialamide
Nialamide may increase the hypotensive activities of Lofexidine.
Nicardipine
Nicardipine may increase the hypotensive activities of Lofexidine.
Nicorandil
Nicorandil may increase the hypotensive activities of Lofexidine.
Nifedipine
The risk or severity of adverse effects can be increased when Lofexidine is combined with Nifedipine.
Nilvadipine
Lofexidine may increase the hypotensive activities of Nilvadipine.
Nimodipine
Nimodipine may increase the hypotensive activities of Lofexidine.
Nisoldipine
Nisoldipine may increase the hypotensive activities of Lofexidine.
Nitrendipine
Nitrendipine may increase the hypotensive activities of Lofexidine.
Nitric Oxide
The risk or severity of adverse effects can be increased when Lofexidine is combined with Nitric Oxide.
Nitroglycerin
The risk or severity of adverse effects can be increased when Lofexidine is combined with Nitroglycerin.
Nitroprusside
Nitroprusside may increase the hypotensive activities of Lofexidine.
Nortriptyline
Nortriptyline may decrease the antihypertensive activities of Lofexidine.
Obinutuzumab
Lofexidine may increase the hypotensive activities of Obinutuzumab.
Olmesartan
Olmesartan may increase the hypotensive activities of Lofexidine.
Opipramol
Opipramol may decrease the antihypertensive activities of Lofexidine.
Oxprenolol
Lofexidine may increase the atrioventricular blocking (AV block) activities of Oxprenolol.
Paclitaxel
The risk or severity of adverse effects can be increased when Lofexidine is combined with Paclitaxel.
Papaverine
The risk or severity of adverse effects can be increased when Lofexidine is combined with Papaverine.
Paregoric
The risk or severity of adverse effects can be increased when Lofexidine is combined with Morphine.
Pargyline
Pargyline may increase the hypotensive activities of Lofexidine.
Penbutolol
Lofexidine may increase the atrioventricular blocking (AV block) activities of Penbutolol.
Pentobarbital
Pentobarbital may increase the hypotensive activities of Lofexidine.
Pentoxifylline
Pentoxifylline may increase the hypotensive activities of Lofexidine.
Perindopril
Perindopril may increase the hypotensive activities of Lofexidine.
Phenelzine
Phenelzine may increase the hypotensive activities of Lofexidine.
Phenobarbital
Phenobarbital may increase the hypotensive activities of Lofexidine.
Phenoxybenzamine
Phenoxybenzamine may increase the hypotensive activities of Lofexidine.
Phentolamine
Phentolamine may increase the hypotensive activities of Lofexidine.
Phentolamine Mesylate
Phentolamine may increase the hypotensive activities of Lofexidine.
Pinacidil
Pinacidil may increase the hypotensive activities of Lofexidine.
Pindolol
Lofexidine may increase the atrioventricular blocking (AV block) activities of Pindolol.
Pipamperone
The risk or severity of adverse effects can be increased when Lofexidine is combined with Pipamperone.
Polythiazide
Polythiazide may increase the hypotensive activities of Lofexidine.
Practolol
Lofexidine may increase the atrioventricular blocking (AV block) activities of Practolol.
Pramipexole
The risk or severity of adverse effects can be increased when Lofexidine is combined with Pramipexole.
Prazosin
Prazosin may increase the hypotensive activities of Lofexidine.
Primidone
Primidone may increase the hypotensive activities of Lofexidine.
Procarbazine
Procarbazine may increase the hypotensive activities of Lofexidine.
Propofol
The risk or severity of adverse effects can be increased when Lofexidine is combined with Propofol.
Propranolol
Lofexidine may increase the atrioventricular blocking (AV block) activities of Propranolol.
Protriptyline
Protriptyline may decrease the antihypertensive activities of Lofexidine.
Quetiapine
The risk or severity of adverse effects can be increased when Lofexidine is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Lofexidine is combined with Quetiapine.
Quinapril
Quinapril may increase the hypotensive activities of Lofexidine.
Quinine
Quinine may increase the hypotensive activities of Lofexidine.
Ramipril
Ramipril may increase the hypotensive activities of Lofexidine.
Rasagiline
Rasagiline may increase the hypotensive activities of Lofexidine.
Remifentanil
The risk or severity of adverse effects can be increased when Lofexidine is combined with Remifentanil.
Rescinnamine
Lofexidine may increase the hypotensive activities of Rescinnamine.
Reserpine
Reserpine may increase the hypotensive activities of Lofexidine.
Rilmenidine
Rilmenidine may increase the hypotensive activities of Lofexidine.
Riociguat
Lofexidine may increase the hypotensive activities of Riociguat.
Risperidone
Lofexidine may increase the hypotensive activities of Risperidone.
Rituximab
Lofexidine may increase the hypotensive activities of Rituximab.
Ropinirole
The risk or severity of adverse effects can be increased when Lofexidine is combined with Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Lofexidine is combined with Ropivacaine.
Rotigotine
The risk or severity of adverse effects can be increased when Lofexidine is combined with Rotigotine.
Sacubitril
The risk or severity of adverse effects can be increased when Lofexidine is combined with Sacubitril.
Secobarbital
Secobarbital may increase the hypotensive activities of Lofexidine.
Selegiline
Selegiline may increase the hypotensive activities of Lofexidine.
Selexipag
Lofexidine may increase the hypotensive activities of Selexipag.
Sevoflurane
The risk or severity of adverse effects can be increased when Lofexidine is combined with Sevoflurane.
Sildenafil
Sildenafil may increase the antihypertensive activities of Lofexidine.
Silodosin
Silodosin may decrease the vasoconstricting activities of Lofexidine.
Sotalol
Lofexidine may increase the atrioventricular blocking (AV block) activities of Sotalol.
Spirapril
Spirapril may increase the hypotensive activities of Lofexidine.
Spironolactone
Spironolactone may decrease the vasoconstricting activities of Lofexidine.
Streptokinase
The risk or severity of adverse effects can be increased when Lofexidine is combined with Streptokinase.
Sufentanil
The risk or severity of adverse effects can be increased when Lofexidine is combined with Sufentanil.
Tadalafil
Tadalafil may increase the antihypertensive activities of Lofexidine.
Talinolol
Lofexidine may increase the atrioventricular blocking (AV block) activities of Talinolol.
Tamsulosin
The risk or severity of adverse effects can be increased when Lofexidine is combined with Tamsulosin.
Telmisartan
Telmisartan may increase the hypotensive activities of Lofexidine.
Terazosin
Terazosin may decrease the vasoconstricting activities of Lofexidine.
Terlipressin
Terlipressin may increase the hypotensive activities of Lofexidine.
Thalidomide
The risk or severity of adverse effects can be increased when Lofexidine is combined with Thalidomide.
Theodrenaline
Lofexidine may increase the hypotensive activities of Theodrenaline.
Thiamylal
Thiamylal may increase the hypotensive activities of Lofexidine.
Thiopental
Thiopental may increase the hypotensive activities of Lofexidine.
Thiopental Sodium
Thiopental may increase the hypotensive activities of Lofexidine.
Thioridazine
The risk or severity of adverse effects can be increased when Lofexidine is combined with Thioridazine.
Tianeptine
Tianeptine may decrease the antihypertensive activities of Lofexidine.
Tibolone
Lofexidine may increase the hypotensive activities of Tibolone.
Timolol
Lofexidine may increase the atrioventricular blocking (AV block) activities of Timolol.
Timolol Anhydrous
Lofexidine may increase the atrioventricular blocking (AV block) activities of Timolol.
Tizanidine
The risk or severity of adverse effects can be increased when Lofexidine is combined with Tizanidine.
Tolazoline
Tolazoline may increase the hypotensive activities of Lofexidine.
Tolcapone
The risk or severity of adverse effects can be increased when Lofexidine is combined with Tolcapone.
Toloxatone
Toloxatone may increase the hypotensive activities of Lofexidine.
Torsemide
Torasemide may increase the hypotensive activities of Lofexidine.
Trandolapril
Trandolapril may increase the hypotensive activities of Lofexidine.
Tranylcypromine
Tranylcypromine may increase the hypotensive activities of Lofexidine.
Travoprost
Travoprost may increase the hypotensive activities of Lofexidine.
Treprostinil
Treprostinil may increase the hypotensive activities of Lofexidine.
Tretinoin
The risk or severity of adverse effects can be increased when Lofexidine is combined with Tretinoin.
Triamterene
The risk or severity of adverse effects can be increased when Lofexidine is combined with Triamterene.
Trichlormethiazide
Trichlormethiazide may increase the hypotensive activities of Lofexidine.
Trimethaphan
Trimethaphan may increase the hypotensive activities of Lofexidine.
Trimipramine
Trimipramine may decrease the antihypertensive activities of Lofexidine.
UNOPROSTONE
Lofexidine may increase the hypotensive activities of Unoprostone.
Urapidil
Urapidil may decrease the vasoconstricting activities of Lofexidine.
Valsartan
Valsartan may increase the hypotensive activities of Lofexidine.
Vardenafil
Vardenafil may increase the antihypertensive activities of Lofexidine.
Venlafaxine
Venlafaxine may increase the tachycardic activities of Lofexidine.
Verapamil
The risk or severity of adverse effects can be increased when Lofexidine is combined with Verapamil.
Vincamine
Lofexidine may increase the hypotensive activities of Vincamine.
Vinpocetine
Lofexidine may increase the hypotensive activities of Vinpocetine.
Xylometazoline
Lofexidine may increase the hypotensive activities of Xylometazoline.
Yohimbine
Yohimbine may decrease the antihypertensive activities of Lofexidine.
Zofenopril
Lofexidine may increase the hypotensive activities of Zofenopril.
